Nomad Power Solutions (NMAD) vs Tonix Pharmaceuticals (TNXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Nomad Power Solutions (NMAD) has outperformed Tonix Pharmaceuticals (TNXP) over the past year, losing 40.6% versus a loss of 85.2%. Over five years, NMAD leads with a -84.6% price change compared with -100.0% for TNXP. Nomad Power Solutions is the larger company by market cap ($47.2 million vs $46.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMAD | TNXP |
|---|---|---|
| Share price | $2.56 | $2.38 |
| Market cap | $47.15M | $46.25M |
| 1-day change | +13.53% | -6.67% |
| YTD return | -34.86% | -84.76% |
| 1-year return | -40.60% | -85.22% |
| 5-year return | -84.58% | -100.00% |
| EPS (TTM) | $-1.01 | $-12.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $13.11M |
| Revenue growth (YoY) | — | +29.85% |
| Net income (latest FY) | $-6.08M | $-124.02M |
| Gross margin | — | 49.34% |
| Operating margin | — | -959.05% |
| Net margin | — | -946.22% |
| 52-week high | $8.38 | $20.56 |
| 52-week low | $2.13 | $2.30 |
| Distance from 52-week high | -69.45% | -88.42% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1769.75% |
| Average volume | 228.96K | 838.83K |
| Shares outstanding | 18.42M | 19.43M |
| Employees | — | 142 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NMAD has outperformed TNXP by 44.6 percentage points over the past year.
About Nomad Power Solutions
NMAD stock →NOMAD Power Solutions, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions.
Health Care · Biotechnology: Pharmaceutical Preparations
About Tonix Pharmaceuticals
TNXP stock →Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia.
Health Care · Biotechnology: Pharmaceutical Preparations · 142 employees
NMAD vs TNXP FAQ
Which is bigger, Nomad Power Solutions or Tonix Pharmaceuticals?
Nomad Power Solutions (NMAD) is larger, with a market capitalization of $47.15M compared with $46.25M for Tonix Pharmaceuticals (TNXP).
Which stock has performed better over the past year, NMAD or TNXP?
NMAD returned -40.60% over the past 12 months, compared with -85.22% for TNXP (price return, excluding dividends). Past performance does not predict future results.
Are Nomad Power Solutions and Tonix Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.